Hal E. Broxmeyer

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by OAbot (talk | contribs) at 17:07, 17 April 2020 (Open access bot: doi added to citation with #oabot.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Hal E. Broxmeyer, Ph.D. is the Distinguished Professor, Mary Margaret Walther Professor Emeritus, and Professor of Microbiology and Immunology at the Indiana University School of Medicine. He received a BS degree from City University of New York, and PhD from New York University.

Research

He is internationally recognized for his work on human umbilical cord blood as a source of transplantable hematopoietic stem cells.[1] In 1989, he first coordinated a study in successfully demonstrating clinical utility of cord blood transplantation to cure a hematological disorder of a child [2] Work from his laboratory has established the field of clinical cord blood transplantation.

Awards and honor

  1. Dirk van Bekkum Award (2002)
  2. E. Donnall Thomas Prize and Lecture (2006)[3]
  3. President, American Society of Hematology (2010)[4]
  4. Elected Fellow of American Association for Advancement of Science (2012)[5]

References

  1. ^ Proc Natl Acad Sci USA. 1989 May; 86(10): 3828-32
  2. ^ N Engl J Med. 1989 Oct 26; 321(17): 1174-8
  3. ^ "E Donnall Thomas Lecture and Prize". Hematology.org. 31 January 2018. Retrieved 8 April 2018.
  4. ^ "Hal E. Broxmeyer, PhD". Hematology.org. 30 March 2016. Retrieved 8 April 2018.
  5. ^ Science, American Association for the Advancement of (30 November 2012). "AAAS News and Notes". Science. 338 (6111): 1166–1171. doi:10.1126/science.338.6111.1166.